[Featured Stocks] Dexamethasone-Related Stocks Rise... Shinil Pharmaceutical Up
[Asia Economy Reporter Minji Lee] As analyses reveal the outstanding effectiveness of Dexamethasone as a treatment for the novel coronavirus infection (COVID-19), related stocks continue to rise.
According to the Korea Exchange on the 21st, Shinil Pharmaceutical, linked to Dexamethasone-related stocks in the KOSDAQ market, recorded the upper price limit for two consecutive days. This is believed to be influenced by Shinil Pharmaceutical producing and selling Shinil Dexamethasone tablets containing the Dexamethasone ingredient. Another related stock, Shinpung Pharmaceutical, is currently under trading suspension. Instead, Shinpung Pharmaceutical Preferred Shares rose to the upper price limit by 29.8%. Other pharmaceutical companies known to hold Dexamethasone injections and tablets, such as Bukwang Pharmaceutical (15%) and Daewon Pharmaceutical (5.41%), are also on the rise.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Don't Throw Away Coffee Grounds" Transformed into 'High-Grade Fuel' in Just 90 Seconds [Reading Science]
- Signed Without Viewing for 1.6 Billion Won... Jamsil and Seongbuk Jeonse Prices Jump 200 Million Won in a Month [Real Estate AtoZ]
- [Breaking] President Lee: "Sharing operating profit before taxes are deducted?... I don't understand"
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
Dexamethasone is a steroid widely used as an anti-inflammatory treatment. Recently, a research team from Oxford in the UK announced that large-scale clinical trial results showed Dexamethasone significantly reduced the mortality rate of severe COVID-19 patients.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
